Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.95
Bid: 18.25
Ask: 18.80
Change: 0.35 (1.88%)
Spread: 0.55 (3.014%)
Open: 18.20
High: 18.95
Low: 18.20
Prev. Close: 18.60
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Mobile agri-waste solution extension order

31 May 2017 07:00

RNS Number : 6230G
BATM Advanced Communications Ld
31 May 2017
 

31 May 2017

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

BATM awarded $1.1m extension order to first Mobile Agri-Waste Solution contract

 

BATM Advanced Communications Limited (LSE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, is pleased to announce that its Eco-Med (formerly 'Pathogenic Waste Treatment and Sterilisation') unit has received an extension order to its contract, originally announced on 7 March 2017, for the delivery of the world's first mobile agri-waste treatment solution, which the Group launched this year.

 

The extension order is worth $1.1m, with 25% upfront payment, which increases the total value of the contract to $3.6m. Delivery will commence later this year, with revenue recognised as the project advances, and is due to complete over the next six months.

 

The extension order is for the delivery of a stationary unit, to complement the mobile unit that is being delivered under the original contract, to enable the customer to deploy the solution for the safe disposal of mass poultry affected by disease and illness more quickly and more efficiently.

 

Poultry affected by disease and illness cannot be transported from their location and are disposed of on-site. BATM's agri-waste treatment solutions utilise the Group's proprietary medical sterilisation solution ("ISS") in the rendering process, allowing the safe treatment of animal remains to generate valuable protein and fat. The treatment process is completely eco-friendly with no hazardous materials or chemicals used and creates no odour.

 

This is the Group's third significant order for a stationary agri-waste treatment unit. The initial two contracts - for treating poultry and bovine remains - are both advancing well.

 

Dr. Zvi Marom, CEO of BATM, said: "We are very pleased to have received another order for our unique agri-waste treatment solution, which, in addition to its cost advantages and savings, provides a perfect ecological solution. This order strengthens our belief that as customers increasingly learn of the advantages of our products, they will adopt them as their preferred solution.

 

"With the increasing demand for our systems and the experience that we have gained since launch, we feel confident in soon marketing our agri-waste solution internationally, and we expect to receive more orders based on the ISS technology this year."

 

 

Enquiries:

 

BATM Advanced Communications

Dr Zvi Marom, Chief Executive Officer

+972 9866 2525

Moti Nagar, Chief Financial Officer

finnCap

Stuart Andrews, Scott Mathieson

+44 20 7220 0500

Shore Capital

Mark Percy, Anita Ghanekar

+44 20 7408 4050 

Luther Pendragon

Harry Chathli, Claire Norbury

+44 20 7618 9100

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTAMMPTMBAJBAR
Date   Source Headline
18th Apr 20247:00 amRNSBATM to deliver Edgility to new Tier 1 customer
8th Apr 20247:00 amRNSBATM awarded new Edgility contract from Cemex
3rd Apr 20247:00 amRNSAnnual Financial Report
26th Mar 20247:00 amRNSBATM receives $2.3m cyber security orders
12th Mar 20247:00 amRNSFull Year Results
29th Feb 20247:00 amRNSNotice of Results
2nd Jan 20247:00 amRNSTotal Voting Rights
30th Nov 20237:03 amRNSBlock Listing Application
27th Nov 20237:00 amRNSBlock Listing Interim Review
30th Oct 20237:00 amRNSBATM receives $3m cyber security order
23rd Oct 20237:00 amRNSADOR Diagnostics secures $7.5m investment
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20237:00 amRNSNew Edgility order for US Emergency Services
9th Oct 20237:00 amRNSResponse to recent developments in Israel
6th Sep 20237:00 amRNSBATM receives $3.4m cyber security contract
29th Aug 20237:00 amRNSInterim Results
13th Jul 202311:30 amRNSResult of AGM and Director Appointment
8th Jun 20237:00 amRNSNotice of Annual General Meeting
6th Jun 20237:00 amRNSCapital Markets Day
5th Jun 20237:00 amRNSNew contract win for Edgility
10th May 20232:30 pmRNSCapital Markets Day and Investor Presentation
17th Apr 20237:00 amRNSEdgility rollout progressing ahead of schedule
4th Apr 20233:30 pmRNSAnnual Financial Report
6th Mar 20237:00 amRNSFull Year Results
24th Feb 20237:00 amRNSNotice of Results
1st Feb 20237:00 amRNSAppointment of Chief Financial Officer
9th Jan 20237:00 amRNSBATM receives $26m cyber security order
3rd Jan 20233:30 pmRNSGrant of Options
21st Dec 202212:00 pmRNSResult of AGM
21st Dec 20227:00 amRNSTransaction in Own Shares and TVR
20th Dec 20227:00 amRNSTransaction in Own Shares and TVR
19th Dec 20227:00 amRNSTransaction in Own Shares and TVR
16th Dec 20227:00 amRNSTransaction in Own Shares and TVR
15th Dec 20227:00 amRNSTransaction in Own Shares and TVR
14th Dec 20227:00 amRNSTransaction in Own Shares and TVR
13th Dec 20227:00 amRNSTransaction in Own Shares and TVR
9th Dec 20227:00 amRNSTransaction in Own Shares and TVR
8th Dec 20227:00 amRNSTrading Update
25th Nov 20221:00 pmRNSBlock Listing Interim Review
24th Nov 20224:00 pmRNSNotice of Annual General Meeting
27th Oct 20227:00 amRNSADOR and BIOASTER to develop STI diagnostic tests
18th Oct 20227:00 amRNSMulti-year contract with CityFibre for Edgility
6th Oct 20227:00 amRNSDirectorate Changes
24th Aug 20227:00 amRNSInterim Results
19th Jul 20227:00 amRNSAppointment of CEO of ADOR Diagnostics
11th Jul 20227:00 amRNSBATM partners with CityFibre for Edgility
16th Jun 20224:36 pmRNSPrice Monitoring Extension
26th May 20227:00 amRNSBlock Listing Interim Review
14th Apr 20229:30 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.